Not finding it? Sign in to also search OpenAlex live.
-
Belzutifan (bel) plus lenvatinib (lenva) versus cabozantinib (cabo) for advanced renal cell carcinoma (RCC) after anti–PD-(L)1 therapy: Open-label phase 3 LITESPARK-011 study.
Robert John Motzer, Se Hoon Park, Ray McDermott, Camillo Porta, Daniel Yick Chin Heng, Mauricio Burotto, +12 more
13citations -
Pharmacokinetic characterization and exposure–response relationship of crovalimab in the COMMODORE 1, 2 and 3 and COMPOSER trials of patients with paroxysmal nocturnal haemoglobinuria2025 British Journal of Clinical Pharmacology article Immunology and Microbiology Complement system in diseases Open access
Valérie F. Cosson, Rong Fu, Austin Gladston Kulasekararaj, Jun‐ichi Nishimura, Jens Panse, Alexander Röth, +14 more
11citations -
Epcoritamab + R2 regimen and responses in high-risk follicular lymphoma, regardless of POD24 status.2023 Journal of Clinical Oncology conference-abstract Medicine Lymphoma Diagnosis and Treatment Open access
Reid W. Merryman, David Belada, Anna Sureda, Sirpa Leppä, Joost S.P. Vermaat, Harald Holte, +13 more
10citations -
Autologous chondrocyte implantation in the knee is effective in skeletally immature patients: a systematic review2022 Knee Surgery Sports Traumatology Arthroscopy review Medicine Osteoarthritis Treatment and Mechanisms Open access
Filippo Migliorini, Joerg Eschweiler, Julia Prinz, Christian David Weber, Ulf Krister Hofmann, Frank Hildebrand, +1 more
6citations -
P774: SUBSTANTIAL INCREASES IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) RED BLOOD CELL CLONE SIZE WITH ORAL IPTACOPAN MONOTHERAPY CONFIRMS CONTROL OF HEMOLYSIS IN COMPLEMENT INHIBITOR-NAÏVE PNH PATIENTS
Régis Peffault de Latour, Bing Han, Jaroslaw Pawel Maciejewski, Yutaka Ueda, Rong Fu, Li Zhang, +15 more
3citations -
Thrombosis and Encapsulated Bacterial Infection Rates in Patients with Paroxysmal Nocturnal Hemoglobinuria Who Received Pegcetacoplan: Nearly 3 Years of Post-Marketing Experience2024 Blood conference-abstract Immunology and Microbiology Complement system in diseases Open access
Gloria Frances Gerber, Richard Kelly, Hisakazu Nishimori, Regina Horneff, Peter Hillmen, Uchendu Orizu Uchendu, +2 more
1citations -
The ATLAS/NOA-29 study protocol: a phase III randomized controlled trial of anterior temporal lobectomy versus gross-total resection in newly-diagnosed temporal lobe glioblastoma
Matthias B. Schneider, Anna‐Laura Potthoff, Yahya Ahmadipour, Valeri Borger, Hans Clusmann, Stephanie Elisabeth Combs, +67 more
1citations -
Nanotechnological Advances in Ocular Therapeutics: A Narrative Review of Drug Delivery Platforms, Clinical Applications, and Translational Challenges2026 Nanotechnology Science and Applications review Pharmacology, Toxicology and Pharmaceutics Advanced Drug Delivery Systems Open access
Uday Pratap Singh Parmar, Rohan Bir Singh, Shilpy Bhullar, Rudraksh Gupta, Ankit Gauba, Maryam Shayan, +2 more
0citations -
Influence of concrete composition on fatigue life: Machine learning-based prediction of the number of cycles to failure2026 International Journal of Fatigue article Engineering Fatigue and fracture mechanics Open access
S. Voss, Silke Scheerer, Raúl Enrique Beltrán Gutiérrez, Thorsten Betz, Chongjie Kang, Steffen Marx
0citations -
Simulation of multi-stage attack and defense mechanisms in smart grids2024 International Journal of Critical Infrastructure Protection article Engineering Smart Grid Security and Resilience Open access
Ömer Sen, Bozhidar Ivanov, Christian Kloos, Christoph Zöll, Philipp Lutat, Martin Henze, +1 more
17citations -
Development of a Quasi–Quantitative Structure–Activity Relationship Model for Prediction of the Immobilization Response of Daphnia magna Exposed to Metal-Based Nanomaterials2022 Environmental Toxicology and Chemistry article Environmental Science Environmental Toxicology and Ecotoxicology Open access
Warisa Bunmahotama, Martina G. Vijver, Willie J.G.M. Peijnenburg
11citations